NNovo Nordisk Read More Novo Nordisk A/S – share repurchase programme2026-08-17 Bagsværd, Denmark, 17 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in…
NNovo Nordisk Read More Novo Nordisk A/S – share repurchase programme2026-08-10 Bagsværd, Denmark, 10 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance…
NNovo Nordisk Read More Novo Nordisk’s Defining Moment: Can a Pill Outweigh a Pipeline Setback?2026-08-04 The arithmetic of Novo Nordisk’s share price has become uncomfortably simple. At Monday’s close of 40.83 euros, the…
NNovo Nordisk Read More Novo Nordisk’s Earnings Reckoning: Options Traders Price In a Rare Double-Digit Swing2026-08-03 For a company that spent the better part of a year selling investors on a diversification story, Novo…
NNovo Nordisk Read More Novo Nordisk’s Market Value Sheds $30 Billion—Here’s Why Shares Are Down2026-07-31 Topline Novo Nordisk shares plunged on Friday, erasing more than $30 billion in market value after the Danish…
NNovo Nordisk Read More Novo Nordisk’s Russian Profit Surprise Masks a Growing Legal Headache2026-07-31 Novo Nordisk investors are digesting a curious paradox: the Danish drugmaker’s Russian subsidiary has more than quadrupled its…
NNovo Nordisk Read More Novo Nordisk Faces a Legal Double Header as Earnings Approach2026-07-30 The Danish pharmaceutical heavyweight is fighting on two legal fronts just days before a pivotal earnings report, with…
NNovo Nordisk Read More Novo Nordisk: A Stock Caught Between Courtroom Battles and a Deep Value Gap2026-07-29 Novo Nordisk’s shares have staged a remarkable recovery from their March lows, yet the Danish pharmaceutical giant remains…
NNovo Nordisk Read More Novo Nordisk’s Legal Blitz and Discounted Ozempic Copy Signal a New Phase in the GLP-1 Wars2026-07-27 The Danish pharmaceutical giant is firing on multiple fronts — in the courtroom, on the pricing front, and…
NNovo Nordisk Read More Novo Nordisk A/S – share repurchase programme2026-07-27 Bagsværd, Denmark, 27 July 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in…
NNovo Nordisk Read More Novo Nordisk Deploys Licensed Semaglutide Copy in South Africa While Waging Legal War on Two Fronts2026-07-27 The Danish drugmaker is fighting for its GLP-1 franchise on multiple fronts — from the courtroom to the…
NNovo Nordisk Read More Novo Nordisk Faces a Two-Pronged Test: Quarterly Results and a Pivotal FDA Decision2026-07-26 The Danish pharmaceutical giant Novo Nordisk enters a defining stretch this week, with its second-quarter earnings due on…